The Global Addison Disease Testing Industry is projected to achieve a revenue of US$ 249.8 million in 2023, with an anticipated compound annual growth rate (CAGR) of 3.4%, eventually reaching a valuation of US$ 349.7 million by 2033. According to a report from Future Market Insights, the increasing adoption of emergency cards and the rise in healthcare …